Equities

Allergy Therapeutics PLC

AGY:LSE

Allergy Therapeutics PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)10.90
  • Today's Change-1.00 / -8.40%
  • Shares traded512.78k
  • 1 Year change72.47%
  • Beta1.4518
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of GBP
(except for per share items)
Fiscal data as of Jun 30 2025202520242023
ASSETS
Cash And Short Term Investments131315
Total Receivables, Net6.036.215.06
Total Inventory141312
Prepaid expenses1.941.622.03
Other current assets, total------
Total current assets353334
Property, plant & equipment, net242423
Goodwill, net3.333.323.35
Intangibles, net0.931.371.79
Long term investments2.842.914.87
Note receivable - long term------
Other long term assets------
Total assets686667
LIABILITIES
Accounts payable4.494.024.09
Accrued expenses8.108.6512
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.882.121.80
Other current liabilities, total134.020.18
Total current liabilities271919
Total long term debt582934
Total debt603136
Deferred income tax0.070.060.45
Minority interest------
Other liabilities, total101111
Total liabilities965965
SHAREHOLDERS EQUITY
Common stock4.774.780.69
Additional paid-in capital155155119
Retained earnings (accumulated deficit)(189)(153)(118)
Treasury stock - common------
Unrealized gain (loss)2.151.781.50
Other equity, total(0.71)(0.82)(0.73)
Total equity(28)7.362.07
Total liabilities & shareholders' equity686667
Total common shares outstanding4,7664,7661,497
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.